Pilot Safety and Feasibility Trial of Mycophenolate and Sirolimus for Prevention of GVHD in Mismatched Unrelated and Related Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 19 Sep 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Mycophenolate mofetil (Primary) ; Mycophenolate mofetil (Primary) ; Sirolimus (Primary)
Indications Graft-versus-host disease
Focus Therapeutic Use

21 Aug 2018 Status changed from recruiting to discontinued due to accrual factor.
04 Apr 2018 Planned End Date changed from 1 Feb 2018 to 1 Aug 2018.
04 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Aug 2018.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com